Advagene Biopharma Co (ROCO:6709) OCF Margin %: 0.00% (As of Dec. 2025)


ROCO:6709 Advagene Biopharma Co Ltd ROCO:6709
34 GF Score
Price NT$24.95
! 2 Warning Signs
View Full Analysis

What is Advagene Biopharma Co OCF Margin %?

Advagene Biopharma Co ROCO:6709 -1.38% 34 OCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates ROCO:6709 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 960 Biotechnology companies, Advagene Biopharma Co ranks worse than 104166.56% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Advagene Biopharma Co's Cash Flow from Operations for the six months ended in Dec. 2025 was NT$-30.64 Mil. Advagene Biopharma Co's Revenue for the six months ended in Dec. 2025 was NT$0.00 Mil. Therefore, Advagene Biopharma Co's OCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Advagene Biopharma Co's current OCF Yield % is -3.64%.

The historical rank and industry rank for Advagene Biopharma Co's OCF Margin % or its related term are showing as below:


ROCO:6709's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -68.59
* Ranked among companies with meaningful OCF Margin % only.

Advagene Biopharma Co OCF Margin % Related Terms

Advagene Biopharma Co OCF Margin % Historical Data

* Premium members only.

The historical data trend for Advagene Biopharma Co's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advagene Biopharma Co OCF Margin % Chart

Advagene Biopharma Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advagene Biopharma Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6709
34GF Score
Advagene Biopharma Co Ltd ROCO:6709
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advagene Biopharma Co OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Advagene Biopharma Co's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-63.33/0
= %

Advagene Biopharma Co's OCF Margin for the quarter that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-30.635/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Advagene Biopharma Co (ROCO:6709) has a OCF Margin % of 0.00% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Advagene Biopharma Co and its competitors. According to the industry distribution chart, Advagene Biopharma Co ranks #999999 out of 960 companies in the Biotechnology industry.
Is Advagene Biopharma Co's OCF Margin % too high?
Advagene Biopharma Co's current OCF Margin % is 0.00%. Based on the distribution chart, Advagene Biopharma Co ranks #999999 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Advagene Biopharma Co has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Advagene Biopharma Co's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Advagene Biopharma Co ranks #999999 out of 960 companies for OCF Margin %. This places Advagene Biopharma Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Advagene Biopharma Co and its competitors. Advagene Biopharma Co's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advagene Biopharma Co stock overvalued right now?
Advagene Biopharma Co (ROCO:6709) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Advagene Biopharma Co's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Advagene Biopharma Co (ROCO:6709), the current OCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advagene Biopharma Co Business Description

Address Sector 1, Neihu Road, 6 Floor, No.308, Neihu District, Taipei, TWN, 114
Advagene Biopharma Co Ltd is a Taiwan based immune-modulatory platform-based biotechnology company. The company has completed technology transfer with DCB for detoxified LT Adjuvant Technology Platform. Its product development includes nasal spray seasonal flu vaccine, nasal spray COVID-19 vaccine, Immunotherapy for COVID-19, Respiratory Allergy Immunotherapy - Allergic Rhinitis and Asthma ,and other vaccines.
34GF Score

Get the complete analysis for ROCO:6709

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$24.95
Price